Establishment of a novel patient-derived Ewing’s sarcoma cell line, NCC-ES1-C1
Author:
Funder
National Cancer Center Research and Development Fund
Publisher
Springer Science and Business Media LLC
Subject
Cell Biology,Developmental Biology,General Medicine
Link
http://link.springer.com/article/10.1007/s11626-018-0302-2/fulltext.html
Reference44 articles.
1. Adams J, Kauffman M (2004) Development of the proteasome inhibitor Velcade (Bortezomib). Cancer Investig 22(2):304–311
2. Alcindor T (2015) Response of refractory Ewing sarcoma to pazopanib. Acta Oncol 54(7):1063–1064. https://doi.org/10.3109/0284186x.2014.971938
3. Attia S, Okuno SH, Robinson SI, Webber NP, Indelicato DJ, Jones RL et al (2015) Clinical activity of pazopanib in metastatic extraosseous Ewing sarcoma. Rare Tumors 7(2):5992–5988. https://doi.org/10.4081/rt.2015.5992
4. Bailly RA, Bosselut R, Zucman J, Cormier F, Delattre O, Roussel M, Thomas G, Ghysdael J (1994) DNA-binding and transcriptional activation properties of the EWS-FLI-1 fusion protein resulting from the t(11;22) translocation in Ewing sarcoma. Mol Cell Biol 14(5):3230–3241
5. Bairoch, A (n.d.). The Cellosaurus: a cell line knowledge resource
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Subtype-selective induction of apoptosis in translocation-related sarcoma cells induced by PUMA and BIM upon treatment with pan-PI3K inhibitors;Cell Death & Disease;2023-02-27
2. Establishment and characterization of a novel patient-derived Ewing sarcoma cell line, NCC-ES2-C1;Human Cell;2022-04-19
3. Current status and perspectives of patient-derived rare cancer models;Human Cell;2020-06-14
4. Current Approaches for Personalized Therapy of Soft Tissue Sarcomas;Sarcoma;2020-04-01
5. Species‐Specific Quantitative Proteomics Profiles of Sarcoma Patient‐Derived Models Closely Reflect Their Primary Tumors;PROTEOMICS – Clinical Applications;2019-09-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3